Clinic-Laboratory Classification of Primary Minor Immunodeficiencies in Humans

Trends in Immunotherapy

Article

Clinic-Laboratory Classification of Primary Minor Immunodeficiencies in Humans

Downloads

https://doi.org/10.54963/ti.v9i4.1318
Dmytro, M. (2025). Clinic-Laboratory Classification of Primary Minor Immunodeficiencies in Humans. Trends in Immunotherapy, 9(4), 188–213. https://doi.org/10.54963/ti.v9i4.1318
Volume 9 Issue 4 (December 2025): In Progress
Copyright (c) 2025 Maltsev Dmytro
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

License

Trends in Immunotherapy (TI)  publishes accepted manuscripts under Creative Commons Attribution 4.0 International (CC BY 4.0). Authors who submit their papers for publication by TI agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse, and transform the content.

Authors

  • Maltsev Dmytro

    Research Institute of Experimental and Clinical Medicine, O’Bogomolets National Medical University, Kyiv 01004, Ukraine

Received: 16 June 2025; Revised: 25 June 2025; Accepted: 14 July 2025; Published: 24 November 2025

Only some primary immunodeficiencies are often found in the population, characterized by a mild clinical phenotype and creating a significant burden on society, so-called primary minor immunodeficiencies (PMD). The study aims to create a clinical and laboratory classification of PMD in humans for basic science and practical medicine. A systematic review of scientific publications in PubMed (MEDLINE) from 1980 to 2025 was conducted using keywords through a sequential two-stage search. The terminology has been clarified and an original clinical and laboratory classification of PMD in humans has been developed according to the following rubrics: origin, affected immune factor, immune system branch and form of immunity, family history, time of debut, frequency in the population, genetic nature, clinical picture, depth of immune factor damage, severity of the patient's condition, duration of the immunological phenotype, evolutionary development scenario, regularity of manifestations, involvement of local and systemic immunity, combinations with each other and with other diseases, curability and some special headings. The significance of the developed classification for fundamental science and clinical practice has been clarified, and promising directions for further research to improve the proposed classification have been indicated. The introduction of a classification will demonstrate the diversity of PMD in humans, enabling both improved clinical diagnosis in individuals with associated immune-dependent pathology and a contribution to the intensification and optimization of clinical research.

Keywords:

Immunocompromise State Immune-Dependent Pathology Immunodiagnosis Immunotherapy Immunoprophylaxis Diversity

References

  1. Redmond, M.T.; Scherzer, R.; Prince, B.T. Novel Genetic Discoveries in Primary Immunodeficiency Disorders. Clin. Rev. Allergy Immunol. 2022, 63, 55–74.
  2. Klangkalya, N.; Fleisher, T.A.; Rosenzweig, S.D. Diagnostic Tests for Primary Immunodeficiency Disorders: Classic and Genetic Testing. Allergy Asthma Proc. 2024, 45, 355–363.
  3. Blanchard-Rohner, G.; Peirolo, A.; Coulon, L.; et al. Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: Six Cases of Classical Ataxia-Telangiectasia and Variant Forms. Front. Immunol. 2022, 13, 791522.
  4. Azizoglu, Z.B.; Babayeva, R.; Haskologlu, Z.S.; et al. DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans. J. Clin. Immunol. 2024, 44, 175. Erratum in: J. Clin. Immunol. 2024, 45, 43.
  5. Van Kessel, D.A.; Horikx, P.E.; Van Houte, A.J.; et al. Clinical and Immunological Evaluation of Patients with Mild IgG1 Deficiency. Clin. Exp. Immunol. 1999, 118, 102–107.
  6. Wiszniewski, W.; Fondaneche, M.C.; Le Deist, F.; et al. Mutation in the Class II Trans-Activator Leading to a Mild Immunodeficiency. J. Immunol. 2001, 167, 1787–1794.
  7. Gomes, L.; Dias, J.A. A Consistent Pattern of Minor Immunodeficiency and Subtle Enteropathy in Children with Multiple Food Allergy. J. Pediatr. Gastroenterol. Nutr. 2004, 39, 101–102.
  8. Litzman, J.; Bartonkova, D.; Lokaj, J. The Efficacy of Levamisole Treatment in Patients with Clinical Signs of Minor Immunodeficiency. Scripta Med. (Brno) 1995, 68, 103–112.
  9. Ojuawo, A.; Milla, P.J.; Lindley, K.J. Non-Infective Colitis in Infancy: Evidence in Favour of Minor Immunodeficiency in Its Pathogenesis. East Afr. Med. J. 1997, 74, 233–236.
  10. Latcham, F.; Merino, F.; Lang, A.; et al. A Consistent Pattern of Minor Immunodeficiency and Subtle Enteropathy in Children with Multiple Food Allergy. J. Pediatr. 2003, 143, 39–47.
  11. Vivarelli, E.; Matucci, A.; Bormioli, S.; et al. Effectiveness of Low-Dose Intravenous Immunoglobulin Therapy in Minor Primary Antibody Deficiencies: A Two-Year Real-Life Experience. Clin. Exp. Immunol. 2021, 205, 346–353.
  12. Smits, B.M.; Budde, I.K.; de Vries, E.; et al. Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency. J. Clin. Immunol. 2021, 41, 382–392.
  13. Yan, C.; Qiu, J.; Pan, X.; et al. Mixed Pulmonary Infection, Asthma, and Nephrotic Syndrome in a Patient Diagnosed with Selective IgA Deficiency: A Case Report. J. Inflamm. Res. 2025, 18, 127–132.
  14. Carrabba, M.; Salvi, M.; Baselli, L.A.; et al. Long-Term Follow-Up in Common Variable Immunodeficiency: The Pediatric-Onset and Adult-Onset Landscape. Front. Pediatr. 2023, 11, 1125994.
  15. Bossuyt, X.; Moens, L.; Van Hoeyveld, E.; et al. Coexistence of (Partial) Immune Defects and Risk of Recurrent Respiratory Infections. Clin. Chem. 2007, 53, 124–130.
  16. Catli, G.; Gao, W.; Foley, C.; et al. Atypical STAT5B Deficiency, Severe Short Stature and Mild Immunodeficiency Associated With a Novel Homozygous STAT5B Variant. Mol. Cell. Endocrinol. 2023, 559, 111799.
  17. van de Vosse, E.; van Ostaijen-Ten Dam, M.M.; Vermaire, R.; et al. Recurrent Respiratory Tract Infections (RRTI) in the Elderly: A Late Onset Mild Immunodeficiency? Clin. Immunol. 2017, 180, 111–119.
  18. Hauck, F.; Magg, T.; Krolo, A.; et al. Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family With Short Statures, Mild Immunodeficiency and Lymphoma. Klin. Padiatr. 2017, 229, 113–117.
  19. Klammt, J.; Neumann, D.; Gevers, E.F.; et al. Dominant-Negative STAT5B Mutations Cause Growth Hormone Insensitivity With Short Stature and Mild Immune Dysregulation. Nat. Commun. 2018, 9, 2105.
  20. Stockdale, C.; Rice, L.; Carter, C.; et al. Novel Case of Tripeptidyl Peptidase 2 Deficiency Associated With Mild Clinical Phenotype. J. Clin. Immunol. 2021, 41, 1123–1127.
  21. Türkkani-Asal, G.; Alanay, Y.; Turul-Ozgür, T.; et al. Mild Clinical Phenotype and Subtle Radiographic Findings in an Infant With Cartilage-Hair Hypoplasia. Turk. J. Pediatr. 2009, 51, 493–496.
  22. Nain, E.; Ulgen, O.; Kiykim, A.; et al. Autosomal Recessive Agammaglobulinemic Patient With a Novel Large Deletion in IGHM Presenting With Mild Clinical Phenotype. Clin. Immunol. 2020, 210, 108295.
  23. Rice, L.; Stockdale, C.; Berry, I.; et al. A Report of Novel STIM1 Deficiency and 6-Year Follow-Up of Two Previous Cases Associated With Mild Immunological Phenotype. J. Clin. Immunol. 2019, 39, 249–256.
  24. Rosado, M.M.; Diamanti, A.P.; Cascioli, S.; et al. Hyper-IgM, Neutropenia, Mild Infections and Low Response to Polyclonal Stimulation: Hyper-IgM Syndrome or Common Variable Immunodeficiency? Int. J. Immunopathol. Pharmacol. 2011, 24, 983–991.
  25. Stercz, B.; Nagy, K.; Ongrádi, J. Adenovirus Infections in Immunocompromised Patients. Orv. Hetil. 2012, 153, 1896–1904. (in Hungarian)
  26. Janssen, L.M.A.; Bassett, P.; Macken, T.; et al. Mild Hypogammaglobulinemia Can Be a Serious Condition. Front. Immunol. 2018, 9, 2384.
  27. Wang, L.; Li, J.; Wu, G.; et al. A Novel Compound Heterozygous Variant in SMARCAL1 Leading to Mild Schimke Immune-Osseous Dysplasia Identified Using Whole-Exome Sequencing. J. Int. Med. Res. 2021, 49, 3000605211010644.
  28. Blot, M.; Boyer, P.; Samson, M.; et al. Should Mild Hypogammaglobulinemia Be Managed as Severe Hypogammaglobulinemia? A Study of 389 Patients With Secondary Hypogammaglobulinemia. Eur. J. Intern. Med. 2014, 25, 837–842.
  29. Brady, M.T.; McGrath, N.; Brouwers, P.; et al. Randomized Study of the Tolerance and Efficacy of High- Versus Low-Dose Zidovudine in Human Immunodeficiency Virus-Infected Children With Mild to Moderate Symptoms (AIDS Clinical Trials Group 128). J. Infect. Dis. 1996, 173, 1097–1106.
  30. Daungsupawong, H.; Wiwanitkit, V. Humoral and Cellular Response to the Third COVID-19 Vaccination in Patients With Inborn Errors of Immunity or Mannose-Binding Lectin Deficiency: Correspondence. Wien. Klin. Wochenschr. 2025, 137, 58–59.
  31. Eigenmann, P.A.; Ambinder, R.F.; Lederman, H.M. Chronic Sinusitis With Acquired Immunoglobulin A (IgA) Deficiency After Bone Marrow Transplantation. Otolaryngol. Head Neck Surg. 1997, 117, S226–S228.
  32. Scanlon, N.; Saklawi, Y.; Rouphael, N. The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients. Front. Immunol. 2020, 11, 582201.
  33. Kovacikova, L.; Krasnanova, V.; Skrak, P.; et al. Immune Abnormalities in Patients With Single Ventricle Circulation Precede the Fontan Procedure. World J. Pediatr. Congenit. Heart Surg. 2017, 8, 672–682.
  34. Hsu, P.; Ma, A.; Barnes, E.H.; et al. The Immune Phenotype of Patients With CHARGE Syndrome. J. Allergy Clin. Immunol. Pract. 2016, 4, 96–103.e2.
  35. Maharaj, A.V.; Ishida, M.; Rybak, A.; et al. QSOX2 Deficiency-Induced Short Stature, Gastrointestinal Dysmotility and Immune Dysfunction. Nat. Commun. 2024, 15, 8420.
  36. Atkinson, T.P. Defective Immune Response to SARS-CoV-2 Immunization in Down Syndrome Correlates With Increased Susceptibility to Severe Illness With Infection. J. Infect. Dis. 2022, 226, 755–756.
  37. Kolb, T.; Fischer, S.; Müller, L.; et al. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients. Kidney360 2021, 2, 1491–1498.
  38. Fernando, S.L.; Jang, H.S.; Li, J. The Immune Dysregulation of Common Variable Immunodeficiency Disorders. Immunol. Lett. 2021, 230, 21–26.
  39. Crescenzo, F.; Turazzini, M.; Rossi, F. Selective IgM Hypogammaglobulinemia and Multiple Sclerosis Treated With Natalizumab and Ofatumumab: A Case Report. J. Pers. Med. 2025, 15, 155.
  40. Nunes-Santos, C.J.; Rosenzweig, S.D. Bacille Calmette-Guérin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017. Front. Immunol. 2018, 9, 1423.
  41. Nauseef, W.M. Quality Control in the Endoplasmic Reticulum: Lessons From Hereditary Myeloperoxidase Deficiency. J. Lab. Clin. Med. 1999, 134, 215–221.
  42. Grumach, A.S.; Goudouris, E.S. Inborn Errors of Immunity: How to Diagnose Them? J. Pediatr. (Rio J.) 2021, 97 Suppl 1, S84–S90.
  43. Antachopoulos, C. Invasive Fungal Infections in Congenital Immunodeficiencies. Clin. Microbiol. Infect. 2010, 16, 1335–1342.
  44. Bagheri, Y.; Sanaei, R.; Yazdani, R.; et al. The Heterogeneous Pathogenesis of Selective Immunoglobulin A Deficiency. Int. Arch. Allergy Immunol. 2019, 179, 231–246.
  45. Coppola, E.; Sgrulletti, M.; Cortesi, M.; et al. The Inborn Errors of Immunity–Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results From the Validation Phase. J. Clin. Immunol. 2024, 44, 47.
  46. Batista, C.H.R.; Smanio, M.C.M.; Poltronieri, P.B.; et al. Selective IgM Deficiency: Evaluation of 75 Patients According to Different Diagnostic Criteria. Immunol. Res. 2024, 73, 15.
  47. Woide, L.K.; Tiezerin, C.S.; Cigana, L.B.; et al. Neonatal Hearing Screening Associated With Congenital Syphilis and HIV. Indian J. Otolaryngol. Head Neck Surg. 2024, 76, 4461–4467.
  48. Abedi, M.R.; Hammarström, L.; Ringdén, O.; et al. Development of IgA Deficiency After Bone Marrow Transplantation: The Influence of Acute and Chronic Graft-Versus-Host Disease. Transplantation 1990, 50, 415–421.
  49. Tanaka, M.; Seki, G.; Ishizawa, K.; et al. Resolution of Henoch–Schönlein Purpura Nephritis After Acquired IgA Deficiency. Pediatr. Nephrol. 2010, 25, 2355–2358.
  50. Jiménez, A.; Alvarez-Doforno, R.; García Rodríguez, M.C.; et al. Autoantibodies in Patients With IgA and IgG2 Deficiencies. APMIS 1991, 99, 327–332.
  51. Goto, R.; Shiota, S.; Kaimori, R.; et al. Disseminated Nontuberculous Mycobacterial Infection in a Patient With Idiopathic CD4 Lymphocytopenia and IFN-γ Neutralizing Antibodies: A Case Report. BMC Infect. Dis. 2023, 23, 58.
  52. Wang, B.; Singh, H.; Ellis, M.; et al. Hidden in the Absence: Clinicopathologic Insights on Kidney Diseases Associated With Selective IgA Deficiency. Lab. Invest. 2025, 105, 104163.
  53. Li, Y.; Choudhary, M.C.; Regan, J.; et al. SARS-CoV-2 Viral Clearance and Evolution Varies by Type and Severity of Immunodeficiency. Sci. Transl. Med. 2024, 16, eadk1599.
  54. Cho, Y.N.; Kee, S.J.; Lee, S.J.; et al. Numerical and Functional Deficiencies of Natural Killer T Cells in Systemic Lupus Erythematosus: Their Deficiency Related to Disease Activity. Rheumatol. 2011, 50, 1054–1063.
  55. Mickey, D.; Camacho, J.V.; Khan, A.; et al. Immunodeficiency: Quantitative and Qualitative Phagocytic Cell Defects. Allergy Asthma Proc. 2024, 45, 299–304.
  56. Gunn, E.; Powers, J.M.; Rahman, A.F.; et al. Diagnosis and Management of Isolated Neutropenia: A Survey of Pediatric Hematologist Oncologists. Pediatr. Blood Cancer 2023, 70, e29946.
  57. Huynh, I.; Woody, D.M.; Ahmed-Khan, M.A.; et al. Lost and Found: Misdiagnosis of AIDS-Related Bone Marrow Suppression as Neutropenic Fever and Benign Ethnic Neutropenia in a Patient With Congenital HIV. Cureus 2024, 16, e68632.
  58. Hysong, M.R.; Shuey, M.M.; Huffman, J.E.; et al. Characterization of the Phenotypic Consequences of the Duffy-Null Genotype. Blood Adv. 2025, 9, 1452–1462.
  59. Fattizzo, B.; Bosi, A.; Sorrenti, M.; et al. Natural History of Chronic Idiopathic Neutropenia of the Adult. Sci. Rep. 2024, 14, 21891.
  60. Horwitz, M.S.; Corey, S.J.; Grimes, H.L.; et al. ELANE Mutations in Cyclic and Severe Congenital Neutropenia: Genetics and Pathophysiology. Hematol. Oncol. Clin. North Am. 2013, 27, 19–41.
  61. Magen, E.; Geishin, A.; Weizman, A.; et al. High Rates of Mood Disorders in Patients With Chronic Idiopathic Eosinopenia. Brain Behav. Immun. Health 2024, 40, 100847.
  62. Belohlavkova, P.; Hrochova, K.; Fatorova, I.; et al. MonoMAC Syndrome With GATA2 Novel Mutation: A Case Report. Leuk. Res. Rep. 2022, 18, 100346.
  63. Milioglou, I.; Kalaitzidou, I.; Ladomenou, F. Interpretation of Lymphocyte Subset Counts by the General Pediatrician. Pediatr. Int. 2019, 61, 16–22.
  64. Orange, J.S. How I Manage Natural Killer Cell Deficiency. J. Clin. Immunol. 2020, 40, 13–23.
  65. Jordan, M.A.; Fletcher, J.; Baxter, A.G. Genetic Control of NKT Cell Numbers. Immunol. Cell Biol. 2004, 82, 276–284.
  66. de Vries, E.; Koene, H.R.; Vossen, J.M.; et al. Identification of an Unusual Fc Gamma Receptor IIIa (CD16) on Natural Killer Cells in a Patient With Recurrent Infections. Blood 1996, 88, 3022–3027.
  67. Petrides, P.E. Molecular Genetics of Peroxidase Deficiency. J. Mol. Med. 1998, 76, 688–698.
  68. Nakagawa, T.; Ikemoto, T.; Takeuchi, T.; et al. Eosinophilic Peroxidase Deficiency: Identification of a Point Mutation (D648N) and Prediction of Structural Changes. Hum. Mutat. 2001, 17, 235–236.
  69. Frampton, S.; Smith, R.; Ferson, L.; et al. Fc Gamma Receptors: Their Evolution, Genomic Architecture, Genetic Variation, and Impact on Human Disease. Immunol. Rev. 2024, 328, 65–97.
  70. van de Winkel, J.G.; de Wit, T.P.; Ernst, L.K.; et al. Molecular Basis for a Familial Defect in Phagocyte Expression of IgG Receptor I (CD64). J. Immunol. 1995, 154, 2896–2903.
  71. Lieberman, J. Anatomy of a Murder: How Cytotoxic T Cells and NK Cells Are Activated, Develop, and Eliminate Their Targets. Immunol. Rev. 2010, 235, 5–9.
  72. Merselis, L.C.; Jiang, S.Y.; Nelson, S.F.; et al. MPEG1/Perforin-2 Haploinsufficiency Associated Polymicrobial Skin Infections and Considerations for Interferon-γ Therapy. Front. Immunol. 2020, 11, 601584.
  73. Willenbring, R.C.; Ikeda, Y.; Pease, L.R.; et al. Human Perforin Gene Variation Is Geographically Distributed. Mol. Genet. Genomic Med. 2018, 6, 44–55.
  74. El Sissy, C.; Rosain, J.; Vieira-Martins, P.; et al. Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-Total Complement Deficiencies. Front. Immunol. 2019, 10, 1936.
  75. McMurray, J.C.; Schornack, B.J.; Weskamp, A.L.; et al. Immunodeficiency: Complement Disorders. Allergy Asthma Proc. 2024, 45, 305–309.
  76. García-Laorden, M.I.; Hernández-Brito, E.; Muñoz-Almagro, C.; et al. Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway. J. Clin. Immunol. 2020, 40, 203–210.
  77. Dogru, D.; Polat, S.E.; Tan, Ç.; et al. Impact of Mannose-Binding Lectin 2 Gene Polymorphisms on Disease Severity in Noncystic Fibrosis Bronchiectasis in Children. Pediatr. Pulmonol. 2020, 55, 1190–1198.
  78. Staels, F.; Meersseman, W.; Stordeur, P.; et al. Terminal Complement Pathway Deficiency in an Adult Patient With Meningococcal Sepsis. Case Rep. Immunol. 2022, 2022, 9057000.
  79. Kato, M.; Kudo, Y.; Hatase, M.; et al. Moyamoya Disease Associated With a Deficiency of Complement Component 6. J. Stroke Cerebrovasc. Dis. 2022, 31, 106601.
  80. Khalil, S.M.; Aqel, S.; Mudawi, D.S.; et al. The First Case Report of Complement Component 7 Deficiency in Qatar and a 10-Year Follow-Up. Front. Immunol. 2023, 14, 1253301.
  81. Mannes, M.; Halbgebauer, R.; Wohlgemuth, L.; et al. Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance? J. Innate Immun. 2023, 15, 412–427.
  82. Watanabe, N.; Suzuki, T.; Kitano, E.; et al. Successful Pregnancy in a Patient Suffering From Recurrent Mid-Trimester Miscarriage With C9 Deficiency After Receiving Cervical Cerclage Followed by Clindamycin and Progesterone: A Case Report. J. Obstet. Gynaecol. Res. 2012, 38, 562–566.
  83. Vivarelli, E.; Matucci, A.; Parronchi, P.; et al. Primary Antibody Deficiencies Represent an Underestimated Comorbidity in Asthma Patients: Efficacy of Immunoglobulin Replacement Therapy in Asthma Control. J. Asthma 2023, 60, 1227–1236.
  84. Ulman, H.; Aygün, A.; Çağlar, D.; et al. Transient Hypogammaglobulinemia of Infancy and Unclassified Syndromic Immunodeficiencies Are Highly Common in Oesophageal Atresia Patients. Scand. J. Immunol. 2024, 99, e13338.
  85. Justiz-Vaillant, A.A.; Hoyte, T.; Davis, N.; et al. A Systematic Review of the Clinical Diagnosis of Transient Hypogammaglobulinemia of Infancy. Children 2023, 10, 1358.
  86. Keles, S.; Artac, H.; Kara, R.; et al. Transient Hypogammaglobulinemia and Unclassified Hypogammaglobulinemia: Similarities and Differences. Pediatr. Allergy Immunol. 2010, 21, 843–851.
  87. Williams, K.; Shorser-Gentile, L.; Sarvode Mothi, S.; et al. Immunoglobulin A Dysgammaglobulinemia Is Associated With Pediatric-Onset Obsessive-Compulsive Disorder. J. Child Adolesc. Psychopharmacol. 2019, 29, 268–275.
  88. Imam, K.; Huang, J.; White, A.A. Isotype Deficiencies (IgG Subclass and Selective IgA, IgM, IgE Deficiencies). Allergy Asthma Proc. 2024, 45, 317–320.
  89. Taietti, I.; Votto, M.; De Filippo, M.; et al. Selective IgM Deficiency: Evidence, Controversies, and Gaps. Diagnostics 2023, 13, 2861.
  90. Gueta, I.; Shoenfeld, Y.; Orbach, H. Intravenous Immune Globulins (IVIg) Treatment for Organizing Pneumonia in a Selective IgG Immune Deficiency State. Immunol. Res. 2014, 60, 165–169.
  91. Filion, C.A.; Taylor-Black, S.; Maglione, P.J.; et al. Differentiation of Common Variable Immunodeficiency From IgG Deficiency. J. Allergy Clin. Immunol. Pract. 2019, 7, 1277–1284.
  92. Vosughimotlagh, A.; Rasouli, S.E.; Rafiemanesh, H.; et al. Clinical Manifestation for Immunoglobulin A Deficiency: A Systematic Review and Meta-Analysis. Allergy Asthma Clin. Immunol. 2023, 19, 75.
  93. Polosukhin, V.V.; Richmond, B.W.; Du, R.H.; et al. Secretory IgA Deficiency in Individual Small Airways Is Associated With Persistent Inflammation and Remodeling. Am. J. Respir. Crit. Care Med. 2017, 195, 1010–1021.
  94. Nemet, S.; Elbirt, D.; Cohen, R.; et al. IgE Deficiency (<2.5 IU/mL) in Children: Clinical Insights From a Population-Based Study of 123,393 Subjects. Pediatr. Allergy Immunol. 2025, 36, e70092.
  95. Vladutiu, A.O. Immunoglobulin D: Properties, Measurement, and Clinical Relevance. Clin. Diagn. Lab. Immunol. 2000, 7, 131–140.
  96. Blanco, E.; Pérez-Andrés, M.; Arriba-Méndez, S.; et al. Defects in Memory B-Cell and Plasma Cell Subsets Expressing Different Immunoglobulin-Subclasses in Patients With CVID and Immunoglobulin Subclass Deficiencies. J. Allergy Clin. Immunol. 2019, 144, 809–824.
  97. Dogru, D.; Dogru, Y.; Atschekzei, F.; et al. Reappraisal of IgG Subclass Deficiencies: A Retrospective Comparative Cohort Study. Front. Immunol. 2025, 16, 1552513.
  98. Zhang, Y.; Clarke, A.; Regan, K.H.; et al. Isolated IgG2 Deficiency Is an Independent Risk Factor for Exacerbations in Bronchiectasis. QJM 2022, 115, 292–297.
  99. Noori, S.A.; Gungor, S. Spinal Epidural Abscess Associated With an Epidural Catheter in a Woman With Complex Regional Pain Syndrome and Selective IgG3 Deficiency: A Case Report. Medicine 2018, 97, e13272.
  100. Koutroumpakis, F.; Phillips, A.E.; Yadav, D.; et al. Serum IgG4 Subclass Deficiency Defines a Distinct, Commonly Encountered, Severe Inflammatory Bowel Disease Subtype. Inflamm. Bowel Dis. 2021, 27, 855–863.
  101. Suzuki, H.; Kaneko, H.; Fukao, T.; et al. Various Expression Patterns of Alpha1 and Alpha2 Genes in IgA Deficiency. Allergol. Int. 2009, 58, 111–117.
  102. Kaneko, H.; Suzuki, H.; Kondo, N. IgA Subclass and IgA Deficiency. Nihon Rinsho Meneki Gakkai Kaishi 2009, 32, 142–148.
  103. Canales-Herrerias, P.; Garcia-Carmona, Y.; Shang, J.; et al. Selective IgA2 Deficiency in a Patient With Small Intestinal Crohn's Disease. J. Clin. Invest. 2023, 133, e167742.
  104. Plebani, A.; Carbonara, A.O.; Bottaro, A.; et al. Two Siblings With Deficiency of IgA1, IgG2, IgG4 and IgE Due to Deletion of Immunoglobulin Heavy Chain Constant Region Genes. Year Immunol. 1993, 7, 231–235.
  105. Drygiannakis, I.; Theodoraki, E.; Tsafaridou, M.; et al. Crohn's Disease-Like Features in a Patient With IgE and Selective IgG1 and IgG3 Deficiency. Cureus 2023, 15, e34655.
  106. Terada, T.; Kaneko, H.; Li, A.L.; et al. Analysis of Ig Subclass Deficiency: First Reported Case of IgG2, IgG4, and IgA Deficiency Caused by Deletion of C Alpha 1, Psi C Gamma, C Gamma 2, C Gamma 4, and C Epsilon in a Mongoloid Patient. J. Allergy Clin. Immunol. 2001, 108, 602–606.
  107. Chen, R.; Mu, H.; Chen, X.; et al. Qualitative Immunoglobulin Deficiency Causes Bacterial Infections in Patients With STAT1 Gain-of-Function Mutations. J. Clin. Immunol. 2024, 44, 124.
  108. Castaño-Jaramillo, L.M.; Munevar, A.; Marín, A.C.; et al. Clinical and Immunological Features of Specific Antibody Deficiency in a Pediatric Hospital in Colombia. Biomedica 2024, 44, 72–79.
  109. Perrard, N.; Stabler, S.; Sanges, S.; et al. Diagnosis, Characteristics, and Outcome of Selective Anti-Polysaccharide Antibody Deficiencies in a Retrospective Cohort of 55 Adult Patients. J. Clin. Immunol. 2025, 45, 82.
  110. Fasshauer, M.; Dinges, S.; Staudacher, O.; et al. Monogenic Inborn Errors of Immunity With Impaired IgG Response to Polysaccharide Antigens but Normal IgG Levels and Normal IgG Response to Protein Antigens. Front. Pediatr. 2024, 12.
  111. Vaz de Castro, P.A.S.; Amaral, A.A.; Almeida, M.G.; et al. Examining the Association Between Serum Galactose-Deficient IgA1 and Primary IgA Nephropathy: A Systematic Review and Meta-Analysis. J. Nephrol. 2024, 37, 2099–2112.
  112. Schmid, J.P.; Güngör, T.; Seger, R. Modern Management of Primary T-Cell Immunodeficiencies. Pediatr. Allergy Immunol. 2014, 25, 300–313.
  113. Dewangan, A.; Singh, J.; Kumar, D.; et al. Disseminated Cryptococcosis in Idiopathic CD4⁺ Lymphocytopenia. Infect. Disord. Drug Targets 2023, 23, e210622206242.
  114. De la Calle-Martin, O.; Hernandez, M.; Ordi, J.; et al. Familial CD8 Deficiency Due to a Mutation in the CD8 Alpha Gene. J. Clin. Invest. 2001, 108, 117–123.
  115. Alromaih, S.; Mfuna-Endam, L.; Bosse, Y.; et al. CD8A Gene Polymorphisms Predict Severity Factors in Chronic Rhinosinusitis. Int. Forum Allergy Rhinol. 2013, 3, 605–611.
  116. Freiberger, T.; Litzman, J.; Vondrusková, E. Role of Aspartic Acid at Position 57 of the HLA-DQ Beta Chain in Sporadic and Familial Forms of Selective IgA Deficiency. Cas. Lek. Cesk. 2001, 140, 770–773.
  117. Sogkas, G.; Dubrowinskaja, N.; Schütz, K.; et al. Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency. Int. Arch. Allergy Immunol. 2022, 183, 337–349.
  118. Hay, B.N.; Martin, J.E.; Karp, B.; et al. Familial Immunodeficiency With Cutaneous Vasculitis, Myoclonus, and Cognitive Impairment. Am. J. Med. Genet. A 2004, 125A, 145–151.
  119. Soler-Palacín, P.; Cobos-Carrascosa, E.; Martín-Nalda, A.; et al. Is Familial Screening Useful in Selective Immunoglobulin A Deficiency? An. Pediatr. (Barc) 2016, 84, 70–78.
  120. Lougaris, V.; Sorlini, A.; Monfredini, C.; et al. Clinical and Laboratory Features of 184 Italian Pediatric Patients Affected With Selective IgA Deficiency (SIgAD): A Longitudinal Single-Center Study. J. Clin. Immunol. 2019, 39, 470–475.
  121. Zhou, Q.; Yang, D.; Ombrello, A.K.; et al. Early-Onset Stroke and Vasculopathy Associated With Mutations in ADA2. N. Engl. J. Med. 2014, 370, 911–920.
  122. Fahl, K.; Silva, C.A.; Pastorino, A.C.; et al. Autoimmune Diseases and Autoantibodies in Pediatric Patients and Their First-Degree Relatives With Immunoglobulin A Deficiency. Rev. Bras. Reumatol. 2015, 55, 197–202.
  123. Endoh, M.; Kaneshige, H.; Tomino, Y.; et al. Selective IgM Deficiency: A Case Study. Tokai J. Exp. Clin. Med. 1981, 6, 327–331.
  124. Dossou-Yovo, O.P.; Lapoumeroulie, C.; Hauchecorne, M.; et al. Variants of the Mannose-Binding Lectin Gene in the Benin Population: Heterozygosity for the p.G57E Allele May Confer a Selective Advantage. Hum. Biol. 2007, 79, 687–697.
  125. Nishikawa, S.; Hamaoka, M.; Nakahara, H.; et al. Management of Acute Cholecystitis in Patient With Cyclic Neutropenia: A Case Report. Surg. Case Rep. 2021, 7, 29.
  126. Kutter, D.; Janecki, J.; Verstraeten, L. Screening for Total and Partial Eosinoperoxidase Deficiency by Flow Cytometry: Prevalence in a General Population, Pathology and Genetic Implications. Redox Rep. 2000, 5, 225–228.
  127. Cappelletti, P.; Doretto, P.; Signori, D.; et al. Eosinophilic Peroxidase Deficiency: Cytochemical and Ultrastructural Characterization of 21 New Cases. Am. J. Clin. Pathol. 1992, 98, 615–622.
  128. Rojas-Torres, D.S.; Bastidas-Yaguana, D.K.; Sierra-Santos, L.; et al. Importance of Selective Immunoglobulin A Deficiency. Semergen 2014, 40, e65–e68.
  129. Jörgensen, G.H.; Gardulf, A.; Sigurdsson, M.I.; et al. Health-Related Quality of Life in Immunodeficient Adults With Selective IgA Deficiency Compared With Age- and Gender-Matched Controls and Identification of Risk Factors for Poor HRQL. Qual. Life Res. 2014, 23, 645–658.
  130. Levin, T.A.; Ownby, D.R.; Smith, P.H.; et al. Relationship Between Extremely Low Total Serum IgE Levels and Rhinosinusitis. Ann. Allergy Asthma Immunol. 2006, 97, 650–652.
  131. Förster-Waldl, E.; Cokoja, L.; Förster, O.; et al. Mannose-Binding Lectin: Comparison of Two Assays for the Quantification of MBL in the Serum of Pediatric Patients. J. Immunol. Methods 2003, 276, 143–146.
  132. Khavandegar, A.; Mahdaviani, S.A.; Zaki-Dizaji, M.; et al. Genetic, Immunologic, and Clinical Features of 830 Patients With Mendelian Susceptibility to Mycobacterial Diseases (MSMD): A Systematic Review. J. Allergy Clin. Immunol. 2024, 153, 1432–1444.
  133. Hargreaves, C.E.; Dhalla, F.; Patel, A.M.; et al. Resolving the Polygenic Aetiology of a Late Onset Combined Immune Deficiency Caused by NFKB1 Haploinsufficiency and Modified by PIK3R1 and TNFRSF13B Variants. Clin. Immunol. 2022, 234, 108910.
  134. Kung, S.J.; Gripp, K.W.; Stephan, M.J.; et al. Selective IgM Deficiency and 22q11.2 Deletion Syndrome. Ann. Allergy Asthma Immunol. 2007, 99, 87–92.
  135. Tayal, A.; Meena, J.P.; Kaur, R.; et al. A Novel Homozygous HAX1 Mutation in a Child With Cyclic Neutropenia: A Case Report and Review. J. Pediatr. Hematol. Oncol. 2022, 44, e420–e423.
  136. Zhang, J.; van Oostrom, D.; Li, J.; et al. Innate Mechanisms in Selective IgA Deficiency. Front. Immunol. 2021, 12, 649112.
  137. Soomann, M.; Bily, V.; Elgizouli, M.; et al. Variants in IGLL1 Cause a Broad Phenotype From Agammaglobulinemia to Transient Hypogammaglobulinemia. J. Allergy Clin. Immunol. 2024, 154, 1313–1324.e7.
  138. Leone, F.; Gori, A.; Cinicola, B.L.; et al. Extra X, Extra Questions: Trisomy X Syndrome and IgA Deficiency—A Case Report. Front. Immunol. 2024, 15, 1518076.
  139. Fekrvand, S.; Abolhassani, H.; Rezaei, N. An Overview of Early Genetic Predictors of IgA Deficiency. Expert Rev. Mol. Diagn. 2024, 24, 715–727.
  140. Vinci, L.; Strahm, B.; Speckmann, C.; et al. The Different Faces of GATA2 Deficiency: Implications for Therapy and Surveillance. Front. Oncol. 2024, 14, 1423856.
  141. Fattizzo, B.; Bosi, A.; Sorrenti, M.; et al. Natural History of Chronic Idiopathic Neutropenia of the Adult. Sci. Rep. 2024, 14, 21891.
  142. Patas, K.; Mavridis, T.; Psarra, K.; et al. Neurolisteriosis in a Previously Asymptomatic Patient With Serum IgM Deficiency: A Case Report. BMC Neurol. 2020, 20, 323.
  143. Tezcan, I.; Ersoy, F.; Sanal, O. IgG Subclasses in Symptomatic IgA Deficiency. Turk. J. Pediatr. 1992, 34, 1–4.
  144. Catanzaro, J.R.; Strauss, J.D.; Bielecka, A.; et al. IgA-Deficient Humans Exhibit Gut Microbiota Dysbiosis Despite Secretion of Compensatory IgM. Sci. Rep. 2019, 9, 13574.
  145. Yazdani, R.; Azizi, G.; Abolhassani, H.; et al. Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Scand. J. Immunol. 2017, 85, 3–12.
  146. Régent, A.; Autran, B.; Carcelain, G.; et al. Idiopathic CD4 Lymphocytopenia: Clinical and Immunologic Characteristics and Follow-Up of 40 Patients. Medicine (Baltimore) 2014, 93, 61–72.
  147. Picado, C.; de Landazuri, I.O.; Vlagea, A.; et al. Spectrum of Disease Manifestations in Patients With Selective Immunoglobulin E Deficiency. J. Clin. Med. 2021, 10, 4160.
  148. Hua, L.; Guo, D.; Liu, X.; et al. Selective IgA Deficiency With Multiple Autoimmune Comorbidities: A Case Report and Literature Review. Iran. J. Immunol. 2023, 20, 232–239.
  149. Milligan, K.L.; Mann, D.; Rump, A.; et al. Complete Myeloperoxidase Deficiency: Beware the "False-Positive" Dihydrorhodamine Oxidation. J. Pediatr. 2016, 176, 204–206.
  150. Casey, C.; Brooke, T.; Davies, R.; et al. Case Report of a Family With Benign Familial Neutropenia and the Implications for the General Dental Practitioner. Dent. Update 2011, 38, 106–108, 110.
  151. Azzi, L.; Croveri, F.; Vinci, R.; et al. Oral Manifestations of Selective IgA-Deficiency: Review and Case-Report. J. Biol. Regul. Homeost. Agents 2017, 31, 113–117.
  152. Errante, P.R.; Perazzio, S.F.; Frazão, J.B.; et al. Primary Immunodeficiency Association With Systemic Lupus Erythematosus: Review of Literature and Lessons Learned by the Rheumatology Division of a Tertiary University Hospital at São Paulo, Brazil. Rev. Bras. Reumatol. Engl. Ed. 2016, 56, 58–68.
  153. Drzymalla, E.; Green, R.F.; Knuth, M.; et al. COVID-19-Related Health Outcomes in People With Primary Immunodeficiency: A Systematic Review. Clin. Immunol. 2022, 243, 109097.
  154. Abdalgani, M.; Hernandez, E.R.; Pedroza, L.A.; et al. Clinical, Immunologic and Genetic Characteristics of 148 Patients With NK Cell Deficiency. J. Allergy Clin. Immunol. 2025, 155, 1623–1634.
  155. Jamee, M.; Alaei, M.R.; Mesdaghi, M.; et al. The Prevalence of Selective and Partial Immunoglobulin A Deficiency in Patients With Autoimmune Polyendocrinopathy. Immunol. Investig. 2022, 51, 778–786.
  156. Moschese, V.; Chini, L.; Graziani, S.; et al. Follow-Up and Outcome of Symptomatic Partial or Absolute IgA Deficiency in Children. Eur. J. Pediatr. 2019, 178, 51–60.
  157. Živković, J.; Lipej, M.; Banić, I.; et al. Respiratory and Allergic Disorders in Children With Severe and Partial Immunoglobulin A Immunodeficiency. Scand. J. Immunol. 2019, 90, e12828.
  158. Barton, J.C.; Bertoli, L.F.; Barton, J.C.; et al. Selective Subnormal IgG3 in 121 Adult Index Patients With Frequent or Severe Bacterial Respiratory Tract Infections. Cell. Immunol. 2016, 299, 50–57.
  159. Barton, J.C.; Bertoli, L.F.; Barton, J.C.; et al. Selective Subnormal IgG1 in 54 Adult Index Patients With Frequent or Severe Bacterial Respiratory Tract Infections. J. Immunol. Res. 2016, 2016, 1405950.
  160. Perazzio, S.F.; Silva, N.P.; Carneiro-Sampaio, M.; et al. Mild and Moderate Mannose Binding Lectin Deficiency Are Associated With Systemic Lupus Erythematosus and Lupus Nephritis in Brazilian Patients. Rev. Bras. Reumatol. Engl. Ed. 2016, 56, 220–227.
  161. Pérez-Portilla, A.; Moraru, M.; Blázquez-Moreno, A.; et al. Identification of the First Cases of Complete CD16A Deficiency: Association With Persistent EBV Infection. J. Allergy Clin. Immunol. 2020, 145(4), 1288–1292.
  162. Dato, C.; Elefante, A.; Coppola, C.; et al. “Borderline” Idiopathic CD4⁺ T-Cell Lymphocytopenia Presenting With Atypical Progressive Multifocal Leukoencephalopathy. J. Neuroimmunol. 2020, 349, 577420.
  163. Green, M.R.; Kennell, A.S.; Larche, M.J.; et al. Natural Killer Cell Activity in Families of Patients With Systemic Lupus Erythematosus: Demonstration of a Killing Defect in Patients. Clin. Exp. Immunol. 2005, 141, 165–173.
  164. Tudhope, S.J.; von Delwig, A.; Falconer, J.; et al. Profound Invariant Natural Killer T-Cell Deficiency in Inflammatory Arthritis. Ann. Rheum. Dis. 2010, 69, 1873–1879.
  165. Janssen, L.M.A.; Macken, T.; Creemers, M.C.W.; et al. Truly Selective Primary IgM Deficiency Is Probably Very Rare. Clin. Exp. Immunol. 2018, 191, 203–211.
  166. Janssen, L.M.A.; Reijnen, I.C.G.M.; Milito, C.; et al. Protocol for the Unclassified Primary Antibody Deficiency (unPAD) Study: Characterization and Classification of Patients Using the ESID Online Registry. PLoS One 2022, 17, e0266083.
  167. Lee, J.; Kim, A.R.; Kang, S.W.; et al. Protracted Course of SARS-CoV-2 Pneumonia in Moderately to Severely Immunocompromised Patients. Clin. Exp. Med. 2023, 23, 2255–2264.
  168. Vertes, D.; Linden, M.D.; Carey, J.L. Idiopathic CD4⁺ T-Lymphocytopenia: Analysis of a Patient With Selective IgA Deficiency and No Evidence of HIV Infection. Cytometry 1995, 22, 40–44.
  169. Moss, R.B.; Carmack, M.A.; Esrig, S. Deficiency of IgG4 in Children: Association of Isolated IgG4 Deficiency With Recurrent Respiratory Tract Infection. J. Pediatr. 1992, 120, 16–21.
  170. Gulez, N.; Karaca, N.E.; Aksu, G.; et al. Increased Percentages of Autoantibodies in Immunoglobulin A-Deficient Children Do Not Correlate With Clinical Manifestations. Autoimmunity 2009, 42, 74–79.
  171. Joller, P.W.; Buehler, A.K.; Hitzig, W.H. Transitory and Persistent IgA Deficiency: Reevaluation of 19 Pediatric Patients Once Found to Be Deficient in Serum IgA. J. Clin. Lab. Immunol. 1981, 6, 97–101.
  172. Aghamohammadi, A.; Mohammadi, J.; Parvaneh, N.; et al. Progression of Selective IgA Deficiency to Common Variable Immunodeficiency. Int. Arch. Allergy Immunol. 2008, 147, 87–92.
  173. Jolles, S.; Tyrer, M.; Johnson, M.; et al. Long-Term Recovery of IgG and IgM Production During HIV Infection in a Patient With Common Variable Immunodeficiency (CVID). J. Clin. Pathol. 2001, 54, 713–715.
  174. Sgrulletti, M.; Costagliola, G.; Giardino, G.; et al. The Evolutionary Scenario of Pediatric Unclassified Primary Antibody Deficiency to Adulthood. J. Clin. Med. 2023, 12, 4206.
  175. Kazi, A.; Strauch, C.; Roy, S.; et al. Temporal Patterns of IgE Levels in Patients With IgE Deficiency. Ann. Allergy Asthma Immunol. 2024, 133, 346–347.
  176. Lim, C.K.; Dahle, C.; Elvin, K.; et al. Reversal of Immunoglobulin A Deficiency in Children. J. Clin. Immunol. 2015, 35, 87–91.
  177. Johnson, M.L.; Keeton, L.G.; Zhu, Z.B.; et al. Age-Related Changes in Serum Immunoglobulins in Patients With Familial IgA Deficiency and Common Variable Immunodeficiency (CVID). Clin. Exp. Immunol. 1997, 108, 477–483.
  178. Erbagci, Z. Noma-Like Gangrenous Cheilitis in a Child With Cyclic Neutropenia Associated With Myeloperoxidase. Pediatr. Dermatol. 2003, 20, 519–523.
  179. Salomon, J.L.; Grimfeld, A.; Tournier, G.; et al. Recurrent Respiratory Disease and IgA Deficiency in Infants and Children (Author's Transl). Sem. Hop. 1981, 57, 1081–1085.
  180. Zhang, S.Y.; Casanova, J.L. Genetic Defects of Brain Immunity in Childhood Herpes Simplex Encephalitis. Nature 2024, 635, 563–573.
  181. Shavit, R.; Maoz-Segal, R.; Frizinsky, S.; et al. Combined Immunodeficiency (CVID and CD4 Lymphopenia) is Associated With a High Risk of Malignancy Among Adults With Primary Immune Deficiency. Clin. Exp. Immunol. 2021, 204, 251–257.
  182. Hogendorf, A.; Szymańska, M.; Krasińska, J.; et al. Clinical Heterogeneity Among Pediatric Patients With Autoimmune Type 1 Diabetes Stratified by Immunoglobulin Deficiency. Pediatr. Diabetes 2021, 22, 707–716.
  183. Erkoçoğlu, M.; Civelek, E.; Kocabaş, C.N. Unusual Presentation: Concurrent IgA Deficiency and Idiopathic Pulmonary Hemosiderosis. Pediatr. Pulmonol. 2016, 51, E34–E36.
  184. Abraitytė, S.; Kotsi, E.; Devlin, L.A.; et al. Unexpected Combination: DiGeorge Syndrome and Myeloperoxidase Deficiency. BMJ Case Rep. 2020, 13, e232741.
  185. Jindal, A.K.; Rawat, A.; Suri, D.; et al. Severe Aspergillus Pneumonia and Pulmonary Artery Hypertension in a Child With Autosomal Recessive Chronic Granulomatous Disease and Selective IgA Deficiency. J. Clin. Immunol. 2017, 37, 333–335.
  186. Bolia, R.; Misra, D.P.; Aggarwal, A.; et al. Paediatric Selective IgM Deficiency and IgG4 Deficiency: An Extremely Unusual Association. BMJ Case Rep. 2014, bcr2014204769.
  187. Kelly, P.; Jack, D.L.; Naeem, A.; et al. Mannose-Binding Lectin Is a Component of Innate Mucosal Defense Against Cryptosporidium parvum in AIDS. Gastroenterology 2000, 119, 1236–1242.
  188. Barton, J.C.; Barton, J.C.; Bertoli, L.F. Clinical and Laboratory Associations of Mannose-Binding Lectin in 219 Adults With IgG Subclass Deficiency. BMC Immunol. 2019, 20, 15.
  189. Bijker, E.M.; Bateman, E.A.L.; Trück, J.; et al. Screening for Immunodeficiencies in Children With Invasive Pneumococcal Disease: Six-Year Experience From a UK Children’s Hospital. Pediatr. Infect. Dis. J. 2022, 41, 575–578.
  190. Nahum, A.; Somech, R.; Shubinsky, G.; et al. Unusual Phenotype in Patients With a Hypomorphic Mutation in the DCLRE1C Gene: IgG Hypergammaglobulinemia With IgA and IgE Deficiency. Clin. Immunol. 2020, 213, 108366.
  191. Orren, A.; Würzner, R.; Potter, P.C.; et al. Properties of a Low Molecular Weight Complement Component C6 Found in Human Subjects With Subtotal C6 Deficiency. Immunology 1992, 75, 10–16.
  192. Boz, V.; Zanchi, C.; Levantino, L.; et al. Druggable Monogenic Immune Defects Hidden in Diverse Medical Specialties: Focus on Overlap Syndromes. World J. Clin. Pediatr. 2022, 11, 136–150.
  193. Aliberti, S.; Amati, F.; Gramegna, A.; et al. Comparison of Different Sets of Immunological Tests to Identify Treatable Immunodeficiencies in Adult Bronchiectasis Patients. ERJ Open Res. 2022, 8, 00388–2021.
  194. Späth, P.J.; Schneider, C.; von Gunten, S. Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations. Arch. Immunol. Ther. Exp. 2017, 65, 215–231.
  195. Tsaknakis, G.; Gallì, A.; Papadakis, S.; et al. Incidence and Prognosis of Clonal Hematopoiesis in Patients With Chronic Idiopathic Neutropenia. Blood 2021, 138, 1249–1257.
  196. Aghamohammadi, A.; Abolhassani, H.; Biglari, M.; et al. Analysis of Switched Memory B Cells in Patients With IgA Deficiency. Int. Arch. Allergy Immunol. 2011, 156, 462–468.
  197. Mousavi, S.; Hosseini, M.H.; Sarandili, S.; et al. Myeloperoxidase Deficiency: A Rare Case. Cureus 2024, 16, e63596.
  198. Louis, A.G.; Gupta, S. Primary Selective IgM Deficiency: An Ignored Immunodeficiency. Clin. Rev. Allergy Immunol. 2014, 46, 104–111.
  199. Koenen, M.H.; Bosma, M.; Roorda, U.A.; et al. A Novel Method to Standardise Serum IgA Measurements Shows an Increased Prevalence of IgA Deficiency in Young Children With Recurrent Respiratory Tract Infections. Clin. Transl. Immunol. 2021, 10, e1344.
  200. Ozkan, H.; Atlihan, F.; Genel, F.; et al. IgA and/or IgG Subclass Deficiency in Children With Recurrent Respiratory Infections and Its Relationship With Chronic Pulmonary Damage. J. Investig. Allergol. Clin. Immunol. 2005, 15, 69–74.
  201. Chennapragada, S.S.; Sharma, S.; Dadi, N.; et al. Real-World Data of Leukopenia Evaluation as Seen in a Community Academic Center. J. Community Hosp. Intern. Med. Perspect. 2023, 13, 126–128.
  202. Lim, L.M.; Chang, J.M.; Wang, I.F.; et al. Atypical X-Linked Agammaglobulinaemia Caused by a Novel BTK Mutation in a Selective Immunoglobulin M Deficiency Patient. BMC Pediatr. 2013, 13, 150.
  203. Hsueh, K.C.; Chiu, H.H.; Lin, H.C.; et al. Transient Hypogammaglobulinemia of Infancy Presenting as Staphylococcus aureus Sepsis With Deep Neck Infection. J. Microbiol. Immunol. Infect. 2005, 38, 141–144.
  204. Ünsal, H.; Ekinci, A.; Aliyeva, G.; et al. Characteristics of Patients With Low Serum IgE Levels and Selective IgE Deficiency: Data From an Immunodeficiency Referral Center. Clin. Immunol. 2025, 270, 110403.
  205. Alska, E.; Doligalska, A.; Napiórkowska-Baran, K.; et al. Global Burden of Allergies: Mechanisms of Development, Challenges in Diagnosis, and Treatment. Life 2025, 15, 878.
  206. Danieli, M.G.; Mezzanotte, C.; Paladini, A.; et al. Hypogammaglobulinemia in Patients Affected by Limited Cutaneous Systemic Sclerosis: Case Series and Review of the Literature. J. Scleroderma Relat. Disord. 2025, 23971983251333851.
  207. Buyukyilmaz, G.; Adiguzel, K.T.; Kocaay, P.; et al. Endocrinopathies in Children With Inborn Errors of Immunity: A Single-Center Experience. J. Pediatr. Endocrinol. Metab. 2025, 38, 735–742.
  208. Cao, Y.; Zhou, Y.; Jia, T. Study on the Correlation Between MASP-2 and Diseases. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2025, 41, 661–666.